Ye Chen

1.3k total citations · 1 hit paper
34 papers, 1.0k citations indexed

About

Ye Chen is a scholar working on Organic Chemistry, Hepatology and Pathology and Forensic Medicine. According to data from OpenAlex, Ye Chen has authored 34 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Organic Chemistry, 13 papers in Hepatology and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Ye Chen's work include Cancer Mechanisms and Therapy (10 papers), Liver physiology and pathology (8 papers) and Synthesis and biological activity (7 papers). Ye Chen is often cited by papers focused on Cancer Mechanisms and Therapy (10 papers), Liver physiology and pathology (8 papers) and Synthesis and biological activity (7 papers). Ye Chen collaborates with scholars based in China, United States and Taiwan. Ye Chen's co-authors include Yu‐Fen Chung, Tom K. Kuo, Kuan‐Der Lee, Oscar K. Lee, Jacqueline Whang‐Peng, S.‐S. Chou, Shi Ding, Neerja Kaushik‐Basu, Tanaji T. Talele and Amartya Basu and has published in prestigious journals such as PLoS ONE, Hepatology and Journal of Hazardous Materials.

In The Last Decade

Ye Chen

33 papers receiving 983 citations

Hit Papers

In vitro Hepatic Differentiation of Human Mesenchymal Ste... 2004 2026 2011 2018 2004 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. In vitro Hepatic Differentiation of Human Mesenchymal Stem Cells
    2004 725 citations Kuan‐Der Lee, Tom K. Kuo et al. Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ye Chen China 10 474 455 428 341 127 34 1.0k
Catalina Atorrasagasti Argentina 23 118 0.2× 76 0.2× 183 0.4× 471 1.4× 16 0.1× 38 1.1k
Robert McKinstry United States 13 87 0.2× 105 0.2× 75 0.2× 475 1.4× 45 0.4× 21 971
Jin Cen China 17 382 0.8× 35 0.1× 482 1.1× 748 2.2× 13 0.1× 24 1.3k
Susan B. Liu United States 9 229 0.5× 33 0.1× 443 1.0× 339 1.0× 10 0.1× 9 971
Mitsuo Toyoda Japan 13 152 0.3× 33 0.1× 372 0.9× 205 0.6× 15 0.1× 31 684
Magdalena Jarosz–Biej Poland 15 108 0.2× 114 0.3× 19 0.0× 362 1.1× 30 0.2× 31 974
Valeria Iansante United Kingdom 10 206 0.4× 41 0.1× 196 0.5× 325 1.0× 5 0.0× 16 664
Midori Hayashida Japan 11 95 0.2× 60 0.1× 77 0.2× 773 2.3× 16 0.1× 15 1.1k
Jiaming Lai China 17 286 0.6× 17 0.0× 249 0.6× 484 1.4× 14 0.1× 57 1.1k
Xiaolan Su China 19 69 0.1× 59 0.1× 33 0.1× 491 1.4× 16 0.1× 44 916

Countries citing papers authored by Ye Chen

Since Specialization
Citations

This map shows the geographic impact of Ye Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ye Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ye Chen more than expected).

Fields of papers citing papers by Ye Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ye Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ye Chen. The network helps show where Ye Chen may publish in the future.

Co-authorship network of co-authors of Ye Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Ye Chen. A scholar is included among the top collaborators of Ye Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ye Chen. Ye Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Jingwen, Jingjun Huang, Yongjian Guo, et al.. (2025). Sorafenib Combined with Tislelizumab and Transarterial Chemoembolization for Advanced-Stage Hepatocellular Carcinoma: A Phase II Study. ImmunoTargets and Therapy. Volume 14. 1187–1200.
2.
Guo, Yongjian, Liteng Lin, Ye Chen, et al.. (2025). Donafenib combined with sintilimab for advanced hepatocellular carcinoma: a single arm phase II trial. BMC Cancer. 25(1). 205–205. 2 indexed citations
3.
Jiang, Yangfu, Qiong Zhao, Zhen Su, et al.. (2025). Chronic exposure to environmental concentrations of enrofloxacin impairs neutrophil function in zebrafish via HPT axis disruption and hematopoietic dysregulation. Journal of Hazardous Materials. 495. 138885–138885. 1 indexed citations
4.
Jiang, Yangfu, Zhen Su, Jing Zheng, Chih-Hung Hsu, & Ye Chen. (2025). Small fish making a big difference: beloved star of environmental toxicology research in the current era. Journal of Zhejiang University SCIENCE B. 26(7). 613–632. 1 indexed citations
5.
Ru, Qin, Bing Ma, Min Yuan, et al.. (2025). Structural characteristics and SARs of EZH2 inhibitors. Molecular Diversity. 1 indexed citations
6.
Wu, Shuang, et al.. (2024). Recent advances in c-Met-based dual inhibitors in the treatment of cancers. European Journal of Medicinal Chemistry. 272. 116477–116477. 13 indexed citations
7.
8.
Zhang, Yadong, Wen Di, Jiwei Shen, et al.. (2023). Application and SARs of Pyrazolo[1,5-a]pyrimidine as Antitumor AgentsScaffold. Current Topics in Medicinal Chemistry. 23(12). 1043–1064. 2 indexed citations
9.
Shen, Jiwei, Jiawei Li, Zhi Wang, et al.. (2023). Design, synthesis, and biological evaluation of novel thieno[3,2-d]pyrimidine derivatives as potent antitumor agents. New Journal of Chemistry. 47(46). 21318–21331. 4 indexed citations
10.
Chen, Ye, Jingxiao Zhang, Yifan He, et al.. (2022). Widely targeted metabolomics reveals stamen petaloid tissue of Paeonia lactiflora Pall. being a potential pharmacological resource. PLoS ONE. 17(9). e0274013–e0274013. 1 indexed citations
11.
12.
Ding, Shi, Mingjuan Zhang, Fang Liu, et al.. (2021). Design, synthesis and biological evaluation of novel N-(3-amino-4-methoxyphenyl)acrylamide derivatives as selective EGFRL858R/T790M kinase inhibitors. Bioorganic Chemistry. 118. 105471–105471. 13 indexed citations
13.
Wang, Yang, et al.. (2020). Design, synthesis and biological evaluation of novel N-[4-(2-fluorophenoxy)pyridin-2-yl]cyclopropanecarboxamide derivatives as potential c-Met kinase inhibitors. European Journal of Medicinal Chemistry. 194. 112244–112244. 42 indexed citations
14.
Wang, Zhen, Wenwen Zhao, Yunlei Hou, et al.. (2020). Design, synthesis and biological evaluation of novel 4-phenoxypyridine based 3-oxo-3,4-dihydroquinoxaline-2-carboxamide derivatives as potential c-Met kinase inhibitors. Bioorganic Chemistry. 105. 104371–104371. 17 indexed citations
15.
Ding, Shi, et al.. (2020). Design, Synthesis and Biological Evaluation of Novel 4-phenoxypyridine Derivatives Containing Semicarbazones Moiety as Potential c-Met Kinase Inhibitors. Anti-Cancer Agents in Medicinal Chemistry. 20(5). 559–570. 1 indexed citations
16.
17.
Chen, Ye, Shegan Gao, Jian‐Min Chen, et al.. (2015). Risk factors for the Long-Term Efficacy, Recurrence, and Metastasis in Small Hepatocellular Carcinomas. Cell Biochemistry and Biophysics. 72(2). 627–631. 8 indexed citations
18.
Kaushik‐Basu, Neerja, et al.. (2008). 4-Thiazolidinones: a novel class of hepatitis C virus NS5B polymerase inhibitors. Frontiers in bioscience. Volume(13). 3857–3857. 36 indexed citations
19.
20.
Lee, Kuan‐Der, Tom K. Kuo, Jacqueline Whang‐Peng, et al.. (2004). In vitro Hepatic Differentiation of Human Mesenchymal Stem Cells. Hepatology. 40(6). 1275–1284. 725 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catalina Atorrasagasti Breakdown of academic impact, for papers by Robert McKinstry Breakdown of academic impact, for papers by Jin Cen Breakdown of academic impact, for papers by Susan B. Liu Breakdown of academic impact, for papers by Mitsuo Toyoda Breakdown of academic impact, for papers by Magdalena Jarosz–Biej Breakdown of academic impact, for papers by Valeria Iansante Breakdown of academic impact, for papers by Midori Hayashida Breakdown of academic impact, for papers by Jiaming Lai Breakdown of academic impact, for papers by Xiaolan Su
Rankless by CCL
2026